Food and Drug Administration (FDA) officials are going to meet soon to consider the next round of COVID-19 vaccines, the agency said on May 7.
The FDA plans to convene its vaccine advisory panel for a virtual meeting on May 22.
The Vaccines and Related Biological Products Advisory Committee “will meet in an open session to discuss and make recommendations on the selection of the 2025-2026 Formula for COVID-19 vaccines for use in the United States,” Grace Graham, the FDA’s deputy commissioner for policy, legislation, and international affairs, said in a Federal Register notice.
No materials have been made available for the meeting as of yet….